Aferdita Spahillari retweeted
Just published in JACC @JACCJournals!🫀
Acute HF care is evolving:
📍Rapid diagnosis
📍Early decongestion
📍Timely GDMT initiation
📍Structured follow-up
📍Focus on long-term outcomes, not just symptom relief
Grateful to have contributed to this international collaboration & learned so much from the exceptional experts involved in this work. Congratulations to @Jolie_Bruno_ and @AlexMebazaa for the leadership & to all co-authors on this important publication🫀
Read the full paper🔗: doi.org/10.1016/j.jacc.2026.…
#HeartFailure #AcuteHeartFailure #JACC @jozinetm @BiykemB @GianluSava @pmyhre
Aferdita Spahillari retweeted
What if we could prevent #heartfailure deaths?
What if #therapies already exist?
What if the #cost was worth it?
In @JCardFail, we show the #costeffective promise of rapid GDMT titration from #STRONGHF
Quad therapy $47,000/QALY, Less for the Brits!
onlinejcf.com/article/S1071-…
Aferdita Spahillari retweeted
Amazing collaboration with my friend @ChingHsuan16 @TuftsCEVR, STRONG-HF trialists, and star mentors @AferditaMD & @AnkurFactorial!
We must overcome the urge to go slow and invest in GDMT titration programs to safely & cost-effectively bend the heart failure mortality curve.
Enjoyed collaborating with @Jolie_Bruno_ and @AlexMebazaa on this leading edge commentary on streamlining GDMT optimization authors.elsevier.com/a/1m055…
Aferdita Spahillari retweeted
Duke HF Annual CME program off to an amazing start! Engaged audience and fantastic talks! Fun to have leaders and colleagues join from across the US
Aferdita Spahillari retweeted
Duke Heart Failure Symposium is underway! Broad regional representation, amazing faculty and exhibitors. Our biggest event yet!
@DukeHeartCenter @DukeHealth @DCRINews @dukeheartfellow
Aferdita Spahillari retweeted
An excellent clinic! 👇🏾
Rapid GDMT implementation via an outpatient GDMT clinic was effective, safe, and associated with improvement in key clinical parameters
doi.org/10.1016/j.jchf.2024.…
Excited to share our latest publication with an incredible group of collaborators (doi.org/10.1002/ehf2.14649). Adding miRNAs predicts HF prognosis better than traditional biomarkers alone. @SaumyaDas_Lab @JJheart_doc
Aferdita Spahillari retweeted
People ask me all the time: how do I overcome #ImposterSyndrome? And honestly, I’m done answering that question. Because here’s the thing: imposter syndrome isn’t a syndrome at all — it's a scheme.
glamour.com/story/impostor-s…
Aferdita Spahillari retweeted
Is guideline quadruple therapy for #HeartFailure with reduced EF cost-effective?
We investigated. Today in @CircOutcomes, we @AnkurFactorial @AferditaMD report a borderline finding: ICER $98,500/QALY
Key Point: It's the Drug Prices.
A Thread:
ahajournals.org/doi/abs/10.1…
